Nothing Special   »   [go: up one dir, main page]

HU9801951D0 - New disubstituted trans 3,4,4,4a,5,6,10b-hexahydro-2h-napht-[1,2-b]-1,4-oxazine derivatives, process for producing them and pharmaceutical compositions containing them - Google Patents

New disubstituted trans 3,4,4,4a,5,6,10b-hexahydro-2h-napht-[1,2-b]-1,4-oxazine derivatives, process for producing them and pharmaceutical compositions containing them

Info

Publication number
HU9801951D0
HU9801951D0 HU9801951A HUP9801951A HU9801951D0 HU 9801951 D0 HU9801951 D0 HU 9801951D0 HU 9801951 A HU9801951 A HU 9801951A HU P9801951 A HUP9801951 A HU P9801951A HU 9801951 D0 HU9801951 D0 HU 9801951D0
Authority
HU
Hungary
Prior art keywords
hexahydro
napht
producing
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU9801951A
Other languages
English (en)
Inventor
Jean-Christophe Harmange
Francoise Lejeune
Mark Millan
Jean-Louis Peglion
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of HU9801951D0 publication Critical patent/HU9801951D0/hu
Publication of HUP9801951A2 publication Critical patent/HUP9801951A2/hu
Publication of HUP9801951A3 publication Critical patent/HUP9801951A3/hu
Publication of HU226059B1 publication Critical patent/HU226059B1/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9801951A 1997-09-01 1998-08-31 Novel disubstituted trans-3,4,4a,5,6,10b-hexahydro-2h-naphto[1,2-b][1,4]oxazine derivatives, process for producing them and pharmaceutical compositions containing them HU226059B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710852A FR2767825A1 (fr) 1997-09-01 1997-09-01 Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (4)

Publication Number Publication Date
HU9801951D0 true HU9801951D0 (en) 1998-11-30
HUP9801951A2 HUP9801951A2 (hu) 2000-02-28
HUP9801951A3 HUP9801951A3 (en) 2000-04-28
HU226059B1 HU226059B1 (en) 2008-04-28

Family

ID=9510643

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801951A HU226059B1 (en) 1997-09-01 1998-08-31 Novel disubstituted trans-3,4,4a,5,6,10b-hexahydro-2h-naphto[1,2-b][1,4]oxazine derivatives, process for producing them and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US6025356A (hu)
EP (1) EP0899267B1 (hu)
JP (1) JP4417451B2 (hu)
CN (1) CN1088064C (hu)
AT (1) ATE229513T1 (hu)
AU (1) AU740928C (hu)
BR (1) BR9803933A (hu)
CA (1) CA2246482C (hu)
DE (1) DE69810034T2 (hu)
DK (1) DK0899267T3 (hu)
ES (1) ES2189108T3 (hu)
FR (1) FR2767825A1 (hu)
HU (1) HU226059B1 (hu)
NO (1) NO311218B1 (hu)
NZ (1) NZ331637A (hu)
PL (1) PL194533B1 (hu)
PT (1) PT899267E (hu)
ZA (1) ZA987963B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
AU2003268292A1 (en) * 2002-08-30 2004-03-19 Biostratum, Inc. Inhibitors of post-amadori advanced glycation end products
MXPA05011225A (es) * 2003-04-18 2005-12-14 Pharmacia & Upjohn Co Llc Politerapias.
FR2906249B1 (fr) 2006-09-26 2008-12-19 Servier Lab Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
WO2009156458A1 (en) * 2008-06-27 2009-12-30 H. Lundbeck A/S Novel phenolic and catecholic amines and prodrugs thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
US4540691A (en) * 1984-04-13 1985-09-10 Nelson Research & Development Co. Dopamine agonists and use thereof
US5486611A (en) * 1989-07-13 1996-01-23 The Upjohn Company Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives
JPH05508408A (ja) * 1990-06-15 1993-11-25 ホイツトビー・リサーチ・インコーポレーテツド ドーパミン作動性薬剤として有用な置換ナフトキサジン類

Also Published As

Publication number Publication date
PT899267E (pt) 2003-04-30
DE69810034D1 (de) 2003-01-23
DE69810034T2 (de) 2003-08-14
NO311218B1 (no) 2001-10-29
HUP9801951A2 (hu) 2000-02-28
FR2767825A1 (fr) 1999-02-26
AU740928C (en) 2002-05-16
US6025356A (en) 2000-02-15
ZA987963B (en) 1999-03-04
BR9803933A (pt) 2001-04-24
JP4417451B2 (ja) 2010-02-17
PL328285A1 (en) 1999-03-15
NO984007D0 (no) 1998-08-31
CA2246482A1 (fr) 1999-03-01
DK0899267T3 (da) 2003-03-10
AU740928B2 (en) 2001-11-15
JPH11130759A (ja) 1999-05-18
ES2189108T3 (es) 2003-07-01
ATE229513T1 (de) 2002-12-15
NO984007L (no) 1999-03-02
CN1088064C (zh) 2002-07-24
EP0899267B1 (fr) 2002-12-11
HUP9801951A3 (en) 2000-04-28
HU226059B1 (en) 2008-04-28
CA2246482C (fr) 2002-11-26
HK1020340A1 (en) 2000-04-14
EP0899267A1 (fr) 1999-03-03
CN1222516A (zh) 1999-07-14
NZ331637A (en) 1999-07-29
AU8302498A (en) 1999-03-11
PL194533B1 (pl) 2007-06-29

Similar Documents

Publication Publication Date Title
HU9700992D0 (en) New 3-(piperid-4-yl)1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, process for their preparation and pharmaceutical compositions containing them
HU9801951D0 (en) New disubstituted trans 3,4,4,4a,5,6,10b-hexahydro-2h-napht-[1,2-b]-1,4-oxazine derivatives, process for producing them and pharmaceutical compositions containing them
ZA964842B (en) Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them
ZA200000336B (en) Cyano-indole serotonin-reuptake inhibitor compounds, a process for their preparation and pharmaceutical compositions containing them.
AU7170496A (en) New tetracyclic 1,4-oxazine compounds, a process for their preparation and pharmaceutical compositions containing them
HUT55783A (en) Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives
PL311843A1 (en) 1,2-bridge 1,4-dihydropyridine derivatives, method of obtaining them, their application and drugs containing such derivatives
AU2052395A (en) New tetracyclic piperidine and 1,4-oxazine compounds, a process for their preparation and pharmaceutical compositions containing them
AU1494295A (en) Novel aminoalkyl benzothiazolinones, process for their preparation and the pharmaceutical compositions which contain them

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees